Ildong Holdings Appoints Kyuwhan Choi as New CEO

Joined Ildong Pharmaceutical in 1987
Extensive Experience in Sales and Marketing

Ildong Holdings announced on March 26 that its board of directors held a meeting and appointed Kyuwhan Choi as the new CEO.

The newly appointed CEO, Choi, joined Ildong Pharmaceutical in 1987 and has held a variety of roles and positions in sales and marketing, including OTC (over-the-counter) and ETC (ethical drug) manager, project manager (PM), branch manager, head of clinic sales, and head of hospital sales.

Kyuhwan Choi, President and CEO of Ildong Holdings. Ildong Holdings

He was promoted to executive director in 2014, serving as head of the global business division and head of management support. In 2016, he moved to Ildong Holdings, the holding company of the Ildong Group, where he took on the role of head of management support. He was promoted to senior executive director in 2019 and to executive vice president in 2024, continuing as head of management support until last year. In January of this year, he was promoted to president and assumed the role of Chief Operating Officer (COO) of Ildong Holdings.

CEO Choi plans to leverage his extensive experience in sales, marketing, and management support to focus on operating the holding company and supporting and managing its affiliates. In particular, under a policy of responsible management, he aims to strengthen efficiency and performance across all affiliates and subordinate organizations.

This content was produced with the assistance of AI translation services.